Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808551418> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2808551418 abstract "Background: Guidelines recommend optimal control of cardiovascular risk factors such as blood pressure, lipids and smoking in addition to glycemic control to reduce the risk of micro and macro-vascular complications in patients with type 2 diabetes mellitus (T2D). However, the extent of comprehensive cardiovascular risk factor control in T2D internationally is not well-known. Methods: A total of 14,169 T2D patients initiating second-line therapy across 37 countries were enrolled in the DISCOVER registry. Optimal cardiovascular risk factor management at study baseline was defined as control of the following risk factors among eligible patients: 1) Systolic BP <140mmHg for all T2D patients; 2) statin prescription in all T2D patients ≥ 40 years, high-intensity statin for those with T2D and ASCVD; 3) non-smoking status for all T2D patients; 4) treatment with ACE-Inhibitor/Angiotensin Receptor Blocker (ACEI/ARB) in patients with T2D and 5) hypertension (HTN)/albuminuria and secondary ASCVD prevention with low-dose aspirin (ASA) in those with T2D and ASCVD. Global and country specific rates of individual and combined risk factor control were calculated. Inter-country variability was estimated using median odds ratios (MOR). Results: Mean age of the DISCOVER cohort was 56.6 (SD= 11.7) years; 7534 (53.2%) were male, mean BMI was 29.6 (SD= 5.9) kg/m 2 , median duration of T2D was 4.1 (IQR 2.0, 7.8) years. A total of 1643 (11.9%) patients had ASCVD, 7221 (51.0%) had HTN and 606 (4.3%) had albuminuria. Overall, among eligible patients, BP was controlled in 67.2% (9043/13457); statin treatment was prescribed in 38.3% (4977/12987); 85.2% (12,075/14169) were not smoking; ACEI/ARB treatment was prescribed in 53.7% (4917/9151), and ASA for secondary prevention was prescribed in 51.6% (847/1643) patients with ASCVD. Of 13,118 patients with 3 or more risk factors, 5312 (40.5%) had optimal control of at least 3 risk factors with wide inter-country variability. Conclusion: In a global registry of individuals with T2D from 37 countries, comprehensive control of ASCVD risk factors was not achieved in most patients, with wide variability among countries. Better strategies are needed to consistently provide comprehensive cardiovascular risk factor control in patients with T2D to improve long term outcomes." @default.
- W2808551418 created "2018-06-21" @default.
- W2808551418 creator A5008251932 @default.
- W2808551418 creator A5008962800 @default.
- W2808551418 creator A5018552456 @default.
- W2808551418 creator A5023436129 @default.
- W2808551418 creator A5025169113 @default.
- W2808551418 creator A5030285688 @default.
- W2808551418 creator A5037246488 @default.
- W2808551418 creator A5043895658 @default.
- W2808551418 creator A5048863829 @default.
- W2808551418 creator A5052533254 @default.
- W2808551418 creator A5061633865 @default.
- W2808551418 creator A5062736539 @default.
- W2808551418 creator A5063764531 @default.
- W2808551418 creator A5064716875 @default.
- W2808551418 creator A5070665675 @default.
- W2808551418 creator A5084734229 @default.
- W2808551418 date "2018-04-01" @default.
- W2808551418 modified "2023-10-02" @default.
- W2808551418 title "Abstract 261: Global Patterns of Comprehensive Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes Mellitus: Insights From the Global DISCOVER Registry" @default.
- W2808551418 doi "https://doi.org/10.1161/circoutcomes.11.suppl_1.261" @default.
- W2808551418 hasPublicationYear "2018" @default.
- W2808551418 type Work @default.
- W2808551418 sameAs 2808551418 @default.
- W2808551418 citedByCount "0" @default.
- W2808551418 crossrefType "journal-article" @default.
- W2808551418 hasAuthorship W2808551418A5008251932 @default.
- W2808551418 hasAuthorship W2808551418A5008962800 @default.
- W2808551418 hasAuthorship W2808551418A5018552456 @default.
- W2808551418 hasAuthorship W2808551418A5023436129 @default.
- W2808551418 hasAuthorship W2808551418A5025169113 @default.
- W2808551418 hasAuthorship W2808551418A5030285688 @default.
- W2808551418 hasAuthorship W2808551418A5037246488 @default.
- W2808551418 hasAuthorship W2808551418A5043895658 @default.
- W2808551418 hasAuthorship W2808551418A5048863829 @default.
- W2808551418 hasAuthorship W2808551418A5052533254 @default.
- W2808551418 hasAuthorship W2808551418A5061633865 @default.
- W2808551418 hasAuthorship W2808551418A5062736539 @default.
- W2808551418 hasAuthorship W2808551418A5063764531 @default.
- W2808551418 hasAuthorship W2808551418A5064716875 @default.
- W2808551418 hasAuthorship W2808551418A5070665675 @default.
- W2808551418 hasAuthorship W2808551418A5084734229 @default.
- W2808551418 hasConcept C126322002 @default.
- W2808551418 hasConcept C134018914 @default.
- W2808551418 hasConcept C156957248 @default.
- W2808551418 hasConcept C2776174234 @default.
- W2808551418 hasConcept C2776839432 @default.
- W2808551418 hasConcept C2777180221 @default.
- W2808551418 hasConcept C2779306644 @default.
- W2808551418 hasConcept C2780473172 @default.
- W2808551418 hasConcept C2910068830 @default.
- W2808551418 hasConcept C50440223 @default.
- W2808551418 hasConcept C555293320 @default.
- W2808551418 hasConcept C71924100 @default.
- W2808551418 hasConcept C72563966 @default.
- W2808551418 hasConcept C84393581 @default.
- W2808551418 hasConceptScore W2808551418C126322002 @default.
- W2808551418 hasConceptScore W2808551418C134018914 @default.
- W2808551418 hasConceptScore W2808551418C156957248 @default.
- W2808551418 hasConceptScore W2808551418C2776174234 @default.
- W2808551418 hasConceptScore W2808551418C2776839432 @default.
- W2808551418 hasConceptScore W2808551418C2777180221 @default.
- W2808551418 hasConceptScore W2808551418C2779306644 @default.
- W2808551418 hasConceptScore W2808551418C2780473172 @default.
- W2808551418 hasConceptScore W2808551418C2910068830 @default.
- W2808551418 hasConceptScore W2808551418C50440223 @default.
- W2808551418 hasConceptScore W2808551418C555293320 @default.
- W2808551418 hasConceptScore W2808551418C71924100 @default.
- W2808551418 hasConceptScore W2808551418C72563966 @default.
- W2808551418 hasConceptScore W2808551418C84393581 @default.
- W2808551418 hasIssue "suppl_1" @default.
- W2808551418 hasLocation W28085514181 @default.
- W2808551418 hasOpenAccess W2808551418 @default.
- W2808551418 hasPrimaryLocation W28085514181 @default.
- W2808551418 hasRelatedWork W2018195085 @default.
- W2808551418 hasRelatedWork W2140167475 @default.
- W2808551418 hasRelatedWork W2263141914 @default.
- W2808551418 hasRelatedWork W2325885830 @default.
- W2808551418 hasRelatedWork W2383009242 @default.
- W2808551418 hasRelatedWork W2553015804 @default.
- W2808551418 hasRelatedWork W2903785509 @default.
- W2808551418 hasRelatedWork W2944849091 @default.
- W2808551418 hasRelatedWork W3107933435 @default.
- W2808551418 hasRelatedWork W4206946711 @default.
- W2808551418 hasVolume "11" @default.
- W2808551418 isParatext "false" @default.
- W2808551418 isRetracted "false" @default.
- W2808551418 magId "2808551418" @default.
- W2808551418 workType "article" @default.